期刊文献+

探讨诊断微量白蛋白尿在非糖尿病人群的性别特异性切点 被引量:1

Analysis of sex specific criteria of microalbuminuria in non-diabetic population
下载PDF
导出
摘要 目的分析非糖尿病人群尿白蛋白与肌酐比值(ACR)的测定结果之间的性别差异,为中国制定诊断微量白蛋白尿的性别特异性标准提供参考数据。方法对北京石景山地区中老年人群进行流行病学调查,无糖尿病者行口服75g葡萄糖耐量试验(OGTT),同时进行问卷调查并对体检的1580例非糖尿病完整资料进行统计,分析ACR的性别差异及原因。结果非糖尿病人群中,男性尿肌酐浓度显著高于女性(8.1vs5.5mmol/L,P<0.05);男性ACR显著低于女性(2.6vs3.1mg/g,P<0.05)。正常血糖(NGT)人群、糖调节受损(IGR)人群及合并后的非糖尿病人群中男性ACR的95%正常上限均为23mg/g,女性ACR的95%正常上限分别为27、32和28mg/g。结论过夜晨尿(次尿)测定ACR诊断不同性别微量白蛋白尿确实存在差异,不同性别应采用不同的诊断标准。 Objective To analyze the sex specific characters of albumin/creatinine ratio (ACR) in non-diabetes population, and to provide reference data for determining the sex-specific criteria of microalburninuria. Methods A total of 1580 non-diabetes adults who passed the 75g oral glucose tolerance test, were included in present study. All of them answered questionnaire and undertook physical examination. All data were analyzed for the sex difference in ACR, and its causes were looked for. Results In the non-diabetes population, the concentration of urine creatinine was significantly higher in males than that in females (8. 1 vs 5. 5mmol/L, P〈0. 05), and the ACR was significantly lower in males than that in females (2. 6 vs 3. 1mg/g, P〈0. 05). In the normal glucose tolerance (NGT), impaired glucose regulation (IGR) and non-diabetes population, the 95% upper normal limit of ACR was 23mg/g in all males, and was 27mg/g, 32mg/g and 28mg/g respectively in females. Conclusion There is sex difference in ACR for the diagnosis of microalbuminuria, so sex-specific criteria should be used.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2007年第2期147-149,共3页 Medical Journal of Chinese People's Liberation Army
基金 首都医学发展科研基金北京医学卫生科技联合攻关项目(2002-1009)
关键词 白蛋白尿 血糖 性别因素 albuminuria blood glucose sex factors
  • 相关文献

参考文献8

  • 1Warram JH,Gearin G,Laffel L,et al.Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio.J Am Soc Nephrol,1996,7:930
  • 2Connell SJ,Hollis S,Tieszen KL,et al.Gender and the clinical usefulness of the albumin:creatinine ratio.Diabet Med,1994,11:32
  • 3Mattix HJ,Hsu CY,Shaykevich S.Use of the albumin/creatinine ratio to detect microalbuminuria:implications of sex and race.J Am Soc Nephrol,2002,13:1034
  • 4IDF Clinical Guidelines Task Force.Global guideline for type 2 diabetes:recommendations for standard,comprehensive,and minimal care.Diabet Med,2006,23:579
  • 5American Diabetes Association.Standards of medical care in diabetes.Diabetes Care,2006,29 (Suppl 1):S4
  • 6Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada.Can J Diabetes,2003,27(Suppl 2):S66
  • 7McIntosh A,Hutchinson A,Marshall S,et al.Clinical guidelines and evidence review for type 2 diabetes.Renal Disease:Prevention and Early Management.Sheffi eld:ScHARR,University of Sheffi eld,2002
  • 8杨艳,陈青云,廖蕴华,赖璐华,陈莹.壮、汉族人群尿微量白蛋白的比较研究[J].华夏医学,2006,19(2):177-178. 被引量:1

二级参考文献4

  • 1HOWEY J E,BROWNING M C,FRASER C G.Biologic variation of urinary albumin,consequences for analysis,specimen collection,interpretation of results,and screening programs[J].Am J Kidney Dis,1989,13:35.
  • 2American Diabetes Association.Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus (Consensus Statement)[J].Diabetes Care,1994,17:1357.
  • 3ERIC L,KNIGHT,GARY C,et al.Albuminuria:moving beyond traditional microalbuminuria cut-points[J].Current Opinion in Nephrology and Hypertension,2003,12:283-284.
  • 4姬景章,李忠信,王秀芬,李曼宇.尿微量白蛋白测定的生物学变异研究[J].天津医科大学学报,2000,6(2):138-141. 被引量:4

同被引文献15

  • 1王琳.尿微量白蛋白测定在高血压、糖尿病早期肾损害诊断中的临床应用[J].中国基层医药,2007,14(6):927-928. 被引量:9
  • 2Kuusisto J,Mykkanen L,Pyorala K,et al.Hyperinsulinemic microalbuminuria.A new risk indicator for coronary heart disease[J].Circulation,1995,91 (3):831-837.
  • 3Luft FC,Agrawal B.Mieroalbuminuria as a predictive factor for cardiovascular events[J].J Cardiovasc Pharmacol,1999,33 (suppl 1):S11-S15.
  • 4Kopyt NP.Slowing progression along the renal disease continuum[J].J Am Osteopath Assoc,2005,105(4):207-215.
  • 5Yuyun MF,Adler AI,Wareham NJ.What is the evidence that microalbuminuria is a predictor of cardiovascular disease events[J] ? Curr Opin Nephrol Hypertens,2005,14(3):271-276.
  • 6Redon J.Measurement of microalbuminuria--what the nephrologist should know[J].Nephrol Dial Transplant,2006,21 (3):573-576.
  • 7Sngura J,Campo C,Ruilope LM.Chronic kidney disease and global cardiovascular risk in essential hypertension[J].Minerva Med,2004,95 (5):375-383.
  • 8Ruilope LM.Kidney dysfunction:a sensitive predictor of cardiovascular risk[J].Am J Hypertens,2001,14(6 Pt 2):213S-217S.
  • 9Ruilope LM,van Veldhuisen DJ,Ritz E,et al.Renal function:the Cinderella of cardiovascular risk profile[J].J Am Coll Cardiol,2001,38(7):1782-1787.
  • 10Horner D,Fliser D,Klimm HP,et al.Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners[J].J Hypertens,1996,14(5):655-660.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部